Company Filing History:
Years Active: 2016-2021
Title: Johan Raud: Innovator in Respiratory Treatments
Introduction
Johan Raud is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of respiratory conditions. With a total of 3 patents to his name, Raud's work focuses on innovative therapeutic solutions.
Latest Patents
One of Raud's latest patents involves the use of angiotensin II type 2 receptor agonist. This invention provides N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-isobutylthiophene-2-sulfonamide, or a pharmaceutically acceptable salt thereof, for treating respiratory virus-induced tissue damage. This damage can be caused by coronaviruses, including severe acute respiratory syndrome coronavirus. The compound has shown promise in alleviating symptoms of diseases caused by these viruses, such as cough, dyspnea, pneumonia, and respiratory distress. Clinical studies indicate that patients with COVID-19 who were administered this compound had a significantly lower need for oxygen treatment compared to those receiving a placebo.
Another significant patent by Raud is the use of pemirolast in the treatment of acute asthma. This invention provides pemirolast, or a pharmaceutically acceptable salt thereof, for therapeutic treatment during acute asthma attacks. The recommended dosage for effective treatment is at least about 110 mg per day.
Career Highlights
Throughout his career, Johan Raud has worked with various companies, including Rspr Pharma AB and Vicore Pharma AB. His innovative approaches have led to advancements in respiratory treatments, showcasing his commitment to improving patient outcomes.
Collaborations
Raud has collaborated with notable professionals in the field, including Carl-Johan Dalsgaard and Rohit Batta. These collaborations have further enhanced the impact of his inventions.
Conclusion
Johan Raud is a distinguished inventor whose work in respiratory treatments has the potential to significantly improve the quality of life for patients suffering from respiratory conditions. His innovative patents reflect a dedication to advancing medical science and addressing critical health challenges.